Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
56
INNV Quote, Financials, Valuation and Earnings
Last price:
$9.53
Seasonality move
:
0.5%
Day range:
$9.10 - $10.69
52-week range:
$2.60 - $10.69
Dividend yield:
0%
P/E ratio:
227.96x
P/S ratio:
1.57x
P/B ratio:
5.60x
Volume:
748.2K
Avg. volume:
363K
1-year change:
220.24%
Market cap:
$1.4B
Revenue:
$853.7M
EPS (TTM):
$0.05
Analysts' Opinion
-
Consensus RatingInnovAge Holding Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $7.00, InnovAge Holding Corp. has an estimated downside of -33.96% from its current price of $10.60.
-
Price Target UpsideAccording to analysts, the highest upside price target is $7.00 representing -100% upside increase from its current price of $10.60.
Fair Value
-
According to the consensus of 2 analysts, InnovAge Holding Corp. has -33.96% downside to fair value with a price target of $7.00 per share.
INNV vs. S&P 500
-
Over the past 5 trading days, InnovAge Holding Corp. has overperformed the S&P 500 by 19.26% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
InnovAge Holding Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
InnovAge Holding Corp. has grown year-over-year revenues for 11 quarters straight. In the most recent quarter InnovAge Holding Corp. reported revenues of $239.7M.
Earnings Growth
-
InnovAge Holding Corp. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter InnovAge Holding Corp. reported earnings per share of $0.08.
Enterprise value:
1.4B
EV / Invested capital:
3.75x
Price / LTM sales:
1.57x
EV / EBIT:
39.29x
EV / Revenue:
1.57x
PEG ratio (5yr expected):
-4.48x
EV / Free cash flow:
28.94x
Price / Operating cash flow:
28.95x
Enterprise value / EBITDA:
25.99x
Gross Profit (TTM):
$167.5M
Return On Assets:
0.63%
Net Income Margin (TTM):
0.36%
Return On Equity:
1.21%
Return On Invested Capital:
0.89%
Operating Margin:
6.72%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $720.8M | $806.6M | $915.4M | $209M | $239.7M | |
| Gross Profit | $101.9M | $121.1M | $167.5M | $31.7M | $47.9M | |
| Operating Income | -$23M | -$9.6M | $36.6M | -$1.4M | $16.1M | |
| EBITDA | -$2.7M | $11.6M | $55.4M | $3.9M | $21M | |
| Diluted EPS | -$0.23 | -$0.19 | $0.05 | -$0.10 | $0.08 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $265.9M | $199.5M | $157M | $168M | $181.9M | |
| Total Assets | $558M | $546.1M | $534.3M | $524.8M | $527.5M | |
| Current Liabilities | $89.3M | $106.2M | $123.1M | $145M | $144.7M | |
| Total Liabilities | $189.6M | $214.3M | $231.3M | $246.8M | $238.7M | |
| Total Equity | $368.4M | $331.8M | $303M | $278M | $288.8M | |
| Total Debt | $85.3M | $103.3M | $108.7M | $101.7M | $90.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$53K | $4.6M | $58.9M | $6.8M | $21.4M | |
| Cash From Investing | -$36.1M | $1.5M | -$11.9M | $4.4M | -$2.9M | |
| Cash From Financing | -$9.2M | -$14.1M | -$9.8M | -$4.1M | -$2.4M | |
| Free Cash Flow | -$12.9M | -$2.7M | $49.8M | $5.4M | $19M | |
INNV
Sector
Market Cap
$1.4B
$25.5M
Price % of 52-Week High
99.16%
50%
Dividend Yield
0%
0%
Shareholder Yield
0.16%
-1.62%
1-Year Price Total Return
220.24%
-17.47%
Beta (5-Year)
--
0.490
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$9.30
200-day SMA
Buy
Level
$5.05
Bollinger Bands (100)
Buy
Level
4.63 - 7.41
Chaikin Money Flow
Buy
Level
13M
20-day SMA
Buy
Level
$8.63
Relative Strength Index (RSI14)
Buy
Level
78.13
ADX Line
Buy
Level
48.24
Williams %R
Sell
Level
-3.0717
50-day SMA
Buy
Level
$6.82
MACD (12, 26)
Buy
Level
0.86
25-day Aroon Oscillator
Buy
Level
84
On Balance Volume
Sell
Level
-4.4M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3633)
Buy
CA Score
(Annual)
Level (-0.0784)
Buy
Beneish M-Score
(Annual)
Level (-3.2545)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (1.1656)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
InnovAge Holding Corp. engages in managing the care of high-cost, frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). The company program is dedicated to enabling older adults to age independently in their own homes for as long as safely possible. It offers interdisciplinary care teams and community-based care delivery models. The company was founded in May 2007 and is headquartered in Denver, CO.
Stock Forecast FAQ
In the current month, INNV has received 0 Buy ratings 2 Hold ratings, and 0 Sell ratings. The INNV average analyst price target in the past 3 months is $7.00.
-
Where Will InnovAge Holding Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that InnovAge Holding Corp. share price will drop to $7.00 per share over the next 12 months.
-
What Do Analysts Say About InnovAge Holding Corp.?
Analysts are divided on their view about InnovAge Holding Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that InnovAge Holding Corp. is a Sell and believe this share price will rise from its current level to $7.00.
-
What Is InnovAge Holding Corp.'s Price Target?
The price target for InnovAge Holding Corp. over the next 1-year time period is forecast to be $7.00 according to 2 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is INNV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for InnovAge Holding Corp. is a Hold. 2 of 2 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of INNV?
You can purchase shares of InnovAge Holding Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase InnovAge Holding Corp. shares.
-
What Is The InnovAge Holding Corp. Share Price Today?
InnovAge Holding Corp. was last trading at $9.53 per share. This represents the most recent stock quote for InnovAge Holding Corp.. Yesterday, InnovAge Holding Corp. closed at $10.60 per share.
-
How To Buy InnovAge Holding Corp. Stock Online?
In order to purchase InnovAge Holding Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get INNV Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
INNV
Sector
P/E ratio
227.96x
22.53x
PEG ratio
-4.48x
-0.01x
P/B ratio
5.60x
1.79x
Price / LTM sales
1.57x
1.52x
Growth Metrics
INNV
Sector
Revenue growth
14.69%
3.33%
Earnings growth
179.82%
12%
Revenue (5-year growth)
8.52%
6.38%
Earnings forecast
$0.04
-$0.20
Profitability
INNV
Sector
Profitability FY 2025
$134.1M
$2.1M
Return on invested capital
0.89%
-33.43%
Return on assets
0.63%
-29.79%
Return on equity
1.21%
-39.36%
Earnings Date
Last Earnings Date
Feb
3
Next Earnings Date
May
5
Estimated Next Earnings Date
May
5
Balance Sheet
INNV
Sector
Total cash
$126M
$24.1M
Short term investments
$45.8M
$23.2M
Total assets
$557.2M
$69.8M
Long term debt
$90.6M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
42
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
93
NBTX alert for Mar 5
Nanobiotix SA [NBTX] is down 6.9% over the past day.
Sell
45
MRNA alert for Mar 5
Moderna, Inc. [MRNA] is down 8.91% over the past day.
Buy
77
SSRM alert for Mar 5
SSR Mining, Inc. [SSRM] is down 6.46% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
